Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.

@article{Bekkenk2000PrimaryAS,
  title={Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.},
  author={Marcel W. Bekkenk and Françoise A. M. J. Geelen and Pieter C van Voorst Vader and Freerk Heule and Mireille Geerts and Willem A van Vloten and Chris J L M Meijer and Rein Willemze},
  journal={Blood},
  year={2000},
  volume={95 12},
  pages={3653-61}
}
To evaluate our diagnostic and therapeutic guidelines, clinical and long-term follow-up data of 219 patients with primary or secondary cutaneous CD30(+) lymphoproliferative disorders were evaluated. The study group included 118 patients with lymphomatoid papulosis (LyP; group 1), 79 patients with primary cutaneous CD30(+) large T-cell lymphoma (LTCL; group 2), 11 patients with CD30(+) LTCL and skin and regional lymph node involvement (group 3), and 11 patients with secondary cutaneous CD30… CONTINUE READING